Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks.
The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care.
High nationwide incidence of multiple sclerosis in sweden.
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
[Argyrophil fibrils in the foci of multiple sclerosis; tissue in the central nervous parenchyma].
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases.

Pages